Market Research Reports

Immunoprotein Diagnostic Testing Market (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assayand Immunoprotein Electrophoresis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

96pages
Published Date: 2014-04-24
 

Description


Immunoprotein diagnostic testing market is continuously fueled with innovative technologies which are shrinking product life cycle and also expanding the boundaries of market. These innovations have also increased the scope of application in various medical fields. The market for immunoprotein diagnostic testing has been segmented according to various immunoproteins, which help in immune response modulation. These include immunoglobulins, complement system proteins, C-reactive protein (CRP), haptoglobin, prealbumin and free light chains (FLC) of immunoglobulins. Each of these proteins plays a characteristic role in the immune response, and hence the level of these immunoproteins has been considered as an indication of diseased state.

Immunoprotein diagnostic testing market has been studied from the perspective of technology platforms such as enzyme linked immunosorbent assay (ELISA), chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, radioimmunoassay, and immunoprotein electrophoresis. Enzyme linked immunosorbent assay is the most widely used technique in the diagnosis of various diseases globally. On the other hand, the market for chemiluminescence assay technology was found to be fastest growing segment owing to broad applications in disease diagnosis, drug testing, oncology and various others.   

Further, immunoprotein diagnostic testing market has also been segmented according to application in diagnosis of various diseases. These include infectious disease testing, allergy testing, endocrine testing, oncology testing, toxicology testing, and autoimmune disease testing. Oncology segment is growing rapidly owing to increased disease prevalence and high cost of assay kits. Geographically, the immunoprotein diagnostic testing market has been segmented into four major regions, namely, North America, Europe, Asia-Pacific, and Rest of the World (RoW). Each of these four geographies is further segmented according to assay technologies. Immunoprotein diagnostic testing market report also details market attractiveness analysis for these geographies. The analysis is based on various factors such as current stage of life cycle, market size, customer base, market competition, and annual growth rate.  

Immunoprotein diagnostic testing market is subjected to various micro as well as macro economic factors. The impact of these factors has been studied to forecast the future trends. The report also provides detailed Porter’s five forces analysis of the immunoprotein diagnostic testing market. Based on in depth analysis and comprehensive market study, key factors driving and restraining the market have been discussed. Moreover lucrative opportunities and relevant recommendations for sustainable growth in the immunoprotein diagnostic testing market also have been suggested.  Each of the market segments has been analyzed on the basis of current and future market size for the period 2011 to 2019, in terms of revenue (USD million), considering 2011 and 2012 as the base years. The compounded annual growth rate (% CAGR) for each market segment has been provided for the forecast period 2013 to 2019 along with the estimations of market size. An exhaustive heat map analysis of key market players such as Abbott Laboratories, Abcam PLC, Diasorin, Enzo Life Sciences, Randox Laboratories, Roche, Siemens, The Binding Site, and Thermo Fisher Scientific is provided in this report. Each of these key market players are profiled in the report considering parameters such as company overview, financial overview, product portfolio, business strategies and recent developments. 

The research methodology was based on primary as well as secondary research. Interviews and discussions with a wide range of key industry participants and opinion leaders revealed real time market scenario. This primary research represented the bulk of the research efforts, which was further supplemented by extensive secondary research. A review of key players’ product literature, annual reports, and press releases supports the market forecast analysis. The 99 pages immunoprotein diagnostic testing market reports described various market dynamics in 30 figures and charts and 9 tables.

Table of Contents


Table of Content

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Secondary Research
      1.3.2 Primary Research
1.4 List of Abbreviations
1.5 Assumptions and Stipulations

Chapter 2 Executive Summary

Chapter 3 Global Immunoprotein Diagnostic Testing Market Overview
3.1 Introduction
3.2 Market Trends and Future Outlook
3.3 Market Dynamics
      3.3.1 Drivers
               3.3.1.1 Rising need for quick and accurate disease diagnosis
               3.3.1.2 Technological advancement
               3.3.1.3 Rising demand for preventive healthcare in developing economies
               3.3.1.4 Strong network of distributors across the globe
               3.3.1.5 Commoditization of products
      3.3.2 Restraints
               3.3.2.1 Higher cost of diagnosis
               3.3.2.2 Installed base of traditional ELISA
      3.3.3 Opportunities
               3.3.3.1 Immunochromatography
               3.3.3.2 Research and development
               3.3.3.3 Expansion in emerging economies
3.1 Porter’s Five Force Analysis for the Global Immunoprotein Diagnostic Testing Market
      3.1.1 Bargaining Power of Suppliers
      3.1.2 Bargaining Power of Buyers
      3.1.3 Threat of Substitutes
      3.1.4 Threat of New Entrants
      3.1.5 Competitive Rivalry
3.2 Market Attractiveness Analysis for the Global Immunoprotein Diagnostic Testing Market, by Geography
3.3 Heat Map Analysis: Global Immunoprotein Diagnostic Testing Market
      3.3.1 Methodology
      3.3.2 Heat Map Analysis for the Global Immunoprotein Diagnostic Testing Market, by key players, 2012

Chapter 4 Global Immunoprotein Diagnostic Testing Market, by Assay Technology
4.1 Introduction
      4.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 - 2019 (USD Million)
4.2 Radioimmunoassay
      4.2.1 Global Radioimmunoassay Market Revenue, 2011 - 2019 (USD Million)
4.3 Enzyme Based Immunoassay
      4.3.1 Global Enzyme Based Immunoassay Market Revenue, 2011 - 2019 (USD Million)
4.4 Chemiluminescence Assay
      4.4.1 Global Chemiluminescence Assay Market Revenue, 2011 - 2019 (USD Million)
4.5 Immunofluorescence Assay
      4.5.1 Global Immunofluorescence Assay Market Revenue, 2011 - 2019 (USD Million)
4.6 Immunoturbidity Assay
      4.6.1 Global Immunoturbidity Assay Market Revenue, 2011 - 2019 (USD Million)
4.7 Immunoprotein Electrophoresis
      4.7.1 Global Immunoprotein Electrophoresis Assay Market Revenue, 2011 - 2019 (USD Million)

Chapter 5 Global Immunoprotein Diagnostic Testing Market, by Immunoprotein Type
5.1 Introduction
      5.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Immunoprotein Type, 2011 - 2019 (USD Million)
5.2 Complement System Proteins Diagnostic Tests
      5.2.1 Global Complement System Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.3 Free Light Chain Diagnostic Tests
      5.3.1 Global Free Light Chain Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.4 Haptoglobin Diagnostic Tests
      5.4.1 Global Haptoglobin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.5 Immunoglobulin Diagnostic Tests
      5.5.1 Global Immunoglobulin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.6 Prealbumin Diagnostic Tests
      5.6.1 Global Prealbumin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
5.7 C-Reactive Protein (CRP) Diagnostic Tests
      5.7.1 Global C-Reactive Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)

Chapter 6 Global Immunoprotein Diagnostic Testing Market, by Application
6.1 Introduction
      6.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Application, 2011 - 2019 (USD Million)
6.2 Infectious Disease Testing
      6.2.1 Global Infectious Disease Testing Market Revenue, 2011 - 2019 (USD Million)
6.3 Oncology Testing
      6.3.1 Global Oncology Testing Market Revenue, 2011 - 2019 (USD Million)
6.4 Endocrine Testing
      6.4.1 Global Endocrine Testing Market Revenue, 2011 - 2019 (USD Million)
6.5 Toxicology Testing
      6.5.1 Global Toxicology Testing Market Revenue, 2011 - 2019 (USD Million)
6.6 Allergy Testing
      6.6.1 Global Allergy Testing Market Revenue, 2011 - 2019 (USD Million)
6.7 Autoimmune Disease Testing
      6.7.1 Global Autoimmune Disease Testing Market Revenue, 2011 - 2019 (USD Million)

Chapter 7 Global Immunoprotein Diagnostic Testing Market, by Geography
7.1 Introduction
      7.1.1 Global Immunoprotein Diagnostic Testing Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
      7.2.1 North America Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
7.3 Europe
      7.3.1 Europe Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
      7.4.1 Asia-Pacific Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
      7.5.1 Rest of the World Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)

Chapter 8 Recommendations
8.1 Untapped allergy testing market
8.2 Future of oncology testing
8.3 Upgrading to latest technology

Chapter 9 Company Profiles
9.1 Abbott Laboratories, Inc.
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Abcam PLC
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 DiaSorin SPA
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies
      9.3.5 Recent Developments
9.4 Enzo Life Sciences, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies
      9.4.5 Recent Developments
9.5 Fujirebio Diagnostics, Inc.
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies
      9.5.5 Recent Developments
9.6 Omega Diagnostics Group PLC
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies
      9.6.5 Recent Developments
9.7 Randox Laboratories Ltd.
      9.7.1 Company Overview
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies
      9.7.5 Recent Developments
9.8 Roche Holding AG
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies
      9.8.5 Recent Developments
9.9 Siemens AG
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies
      9.9.5 Recent Developments
9.10 The Binding Site Group Ltd.
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies
      9.10.5 Recent Developments
9.11 Thermo Fisher Scientific, Inc.
      9.11.1 Company Overview
      9.11.2 Financial Overview
      9.11.3 Product Portfolio
      9.11.4 Business Strategies
      9.11.5 Recent Developments

List of Figures

FIG. 1 Global Immunoprotein Diagnostic Testing Market – Market Segmentation
FIG. 2 Global Immunoprotein Diagnostic Testing Market Revenue, 2011-2019 (USD Million)
FIG. 3 Porter’s Five Force Analysis: Global Immunoprotein Diagnostic Testing Market
FIG. 4 Market Attractiveness Analysis: Global Immunoprotein Diagnostic Testing Market, by Geography
FIG. 5 Heat Map Analysis: Global Immunoprotein Diagnostic Testing Market, by Key Players (2012)
FIG. 6 Global Radioimmunoassay Market Revenue, 2011 - 2019 (USD Million)
FIG. 7 Global Enzyme Based Immunoassay Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Chemiluminescence Assay Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Immunofluorescence Assay Market  Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Immunoturbidity Assay Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Immunoprotein Electrophoresis Assay Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Complement System Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
FIG. 13 Global Free Light Chain Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
FIG. 14 Global Haptoglobin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
FIG. 15 Global Immunoglobulin Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
FIG. 16 Global Prealbumin Dagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
FIG. 17 Global C-Reactive Protein Diagnostic Tests Market Revenue, 2011 - 2019 (USD Million)
FIG. 18 Global Infectious Disease Testing Market Revenue, 2011 - 2019 (USD Million)
FIG. 19 Global Oncology Testing Market Revenue, 2011 - 2019 (USD Million)
FIG. 20 Global Endocrine Testing Market Revenue, 2011 - 2019 (USD Million)
FIG. 21 Global Toxicology Testing Market Revenue, 2011 - 2019 (USD Million)
FIG. 22 Global Allergy Testing Market Revenue, 2011 - 2019 (USD Million)
FIG. 23 Global Autoimmune Disease Testing Market Revenue, 2011 - 2019 (USD Million)
FIG. 24 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 25 Abcam PLC: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 DiaSorin SPA: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Omega Diagnostics Group PLC: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Roche Holding AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Siemens AG (Healthcare Segment): Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Immunoprotein Diagnostic Testing Market
TABLE 2 Global Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 - 2019 (USD Million)
TABLE 3 Global Immunoprotein Diagnostic Testing Market Revenue, by Immunoprotein Type, 2011 - 2019 (USD Million)
TABLE 4 Global Immunoprotein Diagnostic Testing Market Revenue, by Application, 2011 - 2019 (USD Million)
TABLE 5 Global Immunoprotein Diagnostic Testing Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 6 North America Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
TABLE 7 Europe Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
TABLE 8 Asia-Pacific Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)
TABLE 9 Rest of the World Immunoprotein Diagnostic Testing Market Revenue, by Assay Technology, 2011 – 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Immunoproteins being a part of body’s defense mechanism, show characteristic serum concentration under abnormal conditions. Concentration of these proteins has been a prominent indicator for diagnosis of diseased state. On exposure to antigen, their levels increase 10 to 100 fold within 24 to 48 hours. These immunoproteins are thus a potential indicator for disease diagnosis. Application of these immunoproteins have shifted paradigm from microbial testing to rapid testing.

The global market for immunoprotein diagnostic testing was valued at USD 11,019.7 million in 2012 and is expected to grow at a CAGR of 5.7% from 2013 to 2019, to reach an estimated value of USD 15,351.0 million in 2019.

global-immunoprotein-diagnostic-testing-market-revenue-2012

Chemiluminescence assay market was identified as the fastest growing segment owing to ease of use, sensitivity, and wide scope of application. The ELISA market will be fueled by introduction of multiplex ELISA technologies. On the other hand,the radioimmunoassay marketis expected to decline as it is being replaced by better and safer technologies such as ELISA, chemiluminescence assay, immunofluorescence assay and others. Government restriction on the use of radioactive substances have drastically affected the market growth. Compliance with regulatory agencies, high cost of assay equipment and safety devices have further restrained the growth of radioimmunoassay market. Immunofluorescence and immunoturbidity assay segments will be growing at a moderate CAGR of about 5% during the forecast period.

C-reactive proteins (CRP) have gained considerable attention owing to their application in inflammation related disorders. CRP tests are also suggested in strokes, injuries, and cardiovascular diseases.Currently,CRP diagnostic tests are available as ELISA, chemiluminescence and immunoturbidity assay kits. Wide scope of application, excellent market penetration and availability in various technology platforms has propelled the growth of CRP diagnostic tests. Freelite assay manufactured by The Binding Site Ltd., U.K. is the only U.S. FDA approved serum free light chain (FLC) assay in the U.S.Freelite has been approved for monitoring and diagnosis of patients suffering from multiple myeloma. Currently the free light chain diagnostic test’s market is in its initial stages of development. Immunoglobulins are the most explored immunoproteins for disease diagnosis and monitoring. Owing to longstanding market position, and application in varied fields such as infectious disease testing, cancer diagnosis, allergy testing, toxicology testing and others,immunoprotein diagnostic tests market occupies largest marker share of about 30%.

Prevalence of various infectious diseases is on the rise across the globe. The scenario is alarming in developing and under developed economies where due to lack of literacy, and hygienic conditions infections spread faster. According to CDC, approximately 600,000 individuals died due to malaria in 2012 in Africa.Cancer is a also a leading cause of deaths worldwide, and accounts for around 8 million deaths in 2012, according to WHO. Due to these conditions, there is a demand for rapid and accurate diagnosis, which will help in diagnosis in the early stages of disease prognosis. Immunoprotein diagnostic tests have proved to be promising which have provided accurate diagnosis in least possible time. With consistent research and development activities in the field of oncology coupled with flexible assay technologies such as ELISA and CLIA, the oncology diagnostic testing segment is expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research